tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

HOPE Therapeutics, NRx Pharmaceuticals cleared to close Dura Medical acquisition

HOPE Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced it has received final clearance and approval from the Florida Agency for Health Care Administration to proceed closing of the Dura Medical acquisition, in connection with its change of ownership applications, a key regulatory step for closing. Dura is revenue generating and EBITDA positive. The acquisition is expected to be accretive to revenue and EBITDA.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1